Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Apr 29;7(24):35894–35916. doi: 10.18632/oncotarget.9116

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2016 Yang et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

A. Phase transition temperature of the CD90@TMs. B. Drug release property of Rh from the CD90-Rh/TMs and free Rh solution in vitro at 37±0.5°C (mean ± SD, n = 3). C. Release property of Rh from the CD90-Rh/TMs and free Rh solution in vitro at 42±0.5°C (mean ± SD, n = 3). D. Hysteresis Loops of Fe₃O₄ and CD90@TMs. E. Temperature increase curve of the CD90@TMs under an AMF (f = 200 kHz, I = 20 A). F. Physical stability of CD90-Rh/TMs in PBS at 4°C by the end of 1, 2, 3 and 4 weeks (mean ± SD, n = 3). G. Physical stability of CD90-Rh/TMs in DMEM/F12 medium at 4°C by the end of 1, 2, 3 and 4 weeks (mean ± SD, n = 3). Abbreviations: TMs, thermosensitive magnetoliposomes; CD90, cluster of differentiation 90; Rh, Lissamine rhodamine B; DSC, differential scanning calorimeter; AMF, alternating magnetic field; DMEM/F12, Dulbecco's Modified Eagle Media: Nutrient Mixture F-12.